The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(25R)-26-Hydroxy-12,22-dioxo-5alpha-cholestan-3beta,16beta-diyldiacetate ID: ALA1092068
PubChem CID: 46885888
Max Phase: Preclinical
Molecular Formula: C31H48O7
Molecular Weight: 532.72
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)O[C@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC(=O)[C@]2(C)[C@@H]([C@H](C)C(=O)CC[C@@H](C)CO)[C@@H](OC(C)=O)C[C@@H]32)C1
Standard InChI: InChI=1S/C31H48O7/c1-17(16-32)7-10-26(35)18(2)29-27(38-20(4)34)14-25-23-9-8-21-13-22(37-19(3)33)11-12-30(21,5)24(23)15-28(36)31(25,29)6/h17-18,21-25,27,29,32H,7-16H2,1-6H3/t17-,18-,21+,22+,23-,24+,25+,27+,29+,30+,31-/m1/s1
Standard InChI Key: PJEIZYOGVHHVCL-KINUGENKSA-N
Molfile:
RDKit 2D
43 46 0 0 0 0 0 0 0 0999 V2000
1.7741 -11.2986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7616 -12.1315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3790 -12.5355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0495 -12.5355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3331 -12.1190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3790 -13.3601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5487 -12.3939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0495 -13.3601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0485 -11.7234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5612 -11.0488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3331 -13.7724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0495 -10.8738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3331 -11.2861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0995 -12.1190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0995 -13.7724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5857 -10.2273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7616 -10.4698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3873 -11.7109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8116 -12.5355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8116 -13.3601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8603 -10.3422 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.0075 -10.2650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3091 -9.8289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8872 -9.7911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1603 -9.9152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7373 -9.8734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4305 -10.3068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4128 -11.1219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3858 -11.0488 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
0.3248 -12.9353 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
1.7574 -12.9478 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
1.0370 -11.7109 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.5260 -13.7719 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.3316 -9.0046 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8731 -11.7296 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2800 -12.4468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1046 -12.4530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8623 -13.1578 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.2398 -13.3592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9543 -13.7711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2393 -12.5346 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0528 -10.0493 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3831 -14.1847 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
12 1 1 0
13 12 1 0
14 3 1 0
15 6 1 0
16 10 1 0
1 17 1 1
3 18 1 1
19 14 1 0
20 19 1 0
21 25 1 0
22 23 1 0
23 16 1 0
16 24 1 6
25 27 1 0
26 22 1 0
27 26 1 0
27 28 1 6
10 29 1 6
5 30 1 6
2 31 1 6
4 32 1 1
7 9 1 0
4 5 1 0
6 11 1 0
15 20 1 0
20 33 1 1
2 1 1 0
23 34 2 0
3 5 1 0
9 35 1 1
4 2 1 0
35 36 1 0
5 13 1 0
36 37 1 0
6 3 1 0
36 38 2 0
7 2 1 0
33 39 1 0
8 4 1 0
39 40 1 0
9 10 1 0
39 41 2 0
10 1 1 0
12 42 2 0
11 8 1 0
6 43 1 6
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 532.72Molecular Weight (Monoisotopic): 532.3400AlogP: 4.91#Rotatable Bonds: 8Polar Surface Area: 106.97Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.14CX LogD: 4.14Aromatic Rings: ┄Heavy Atoms: 38QED Weighted: 0.44Np Likeness Score: 2.31
References 1. Fernández-Herrera MA, López-Muñoz H, Hernández-Vázquez JM, López-Dávila M, Escobar-Sánchez ML, Sánchez-Sánchez L, Pinto BM, Sandoval-Ramírez J.. (2010) Synthesis of 26-hydroxy-22-oxocholestanic frameworks from diosgenin and hecogenin and their in vitro antiproliferative and apoptotic activity on human cervical cancer CaSki cells., 18 (7): [PMID:20303770 ] [10.1016/j.bmc.2010.02.051 ] 2. Fernández-Herrera MA, Mohan S, López-Muñoz H, Hernández-Vázquez JM, Pérez-Cervantes E, Escobar-Sánchez ML, Sánchez-Sánchez L, Regla I, Pinto BM, Sandoval-Ramírez J.. (2010) Synthesis of the steroidal glycoside (25R)-3β,16β-diacetoxy-12,22-dioxo-5α-cholestan-26-yl β-D-glucopyranoside and its anti-cancer properties on cervicouterine HeLa, CaSki, and ViBo cells., 45 (11): [PMID:20801554 ] [10.1016/j.ejmech.2010.07.051 ]